SHANDONG QILU KING PHARPHARMACEUTICAL CO.,LTD

Company Introduction: SHANDONG QILU KING PHARPHARMACEUTICAL CO.,LTD

SHANDONG QILU KING PHARPHARMACEUTICAL CO.,LTD is a prominent pharmaceutical enterprise based in Jinan, Shandong Province, China. It is a key subsidiary of the larger Qilu Pharmaceutical Group. The company is dedicated to the research, development, manufacturing, and marketing of a diverse portfolio of pharmaceutical products. Its offerings include active pharmaceutical ingredients (APIs), finished dosage forms, and biological products. The therapeutic areas covered span oncology, cardiovascular diseases, anti-infectives, and central nervous system disorders, among others. The company emphasizes innovation, quality control, and adherence to international Good Manufacturing Practices (GMP) standards in its production processes.

Nature of Business:

SHANDONG QILU KING PHARPHARMACEUTICAL CO.,LTD is primarily a manufacturing company (factory). It operates large-scale production facilities in China where it produces its pharmaceutical products.

Regarding Thailand:

While SHANDONG QILU KING PHARPHARMACEUTICAL CO.,LTD is a Chinese manufacturer, it engages in international trade and exports its products globally. Therefore, it is highly probable that its products are distributed and sold in Thailand through local partners or direct exports. In this context, it acts as an exporter (a form of trading) in relation to the Thai market. The company does not have manufacturing facilities or a direct corporate presence (such as a subsidiary office) physically located in Thailand.

SHANDONG QILU KING PHARMACEUTICAL CO.,LTD, as part of the Qilu Pharmaceutical Group, produces and sells a broad range of pharmaceutical products. Their product portfolio typically includes:

Oncology Products: Various anti-cancer drugs, including chemotherapeutics, targeted therapies, and biologics/biosimilars.

Anti-infective Drugs: A wide array of antibiotics (such as cephalosporins, carbapenems, and fluoroquinolones) and antiviral agents.

Cardiovascular Drugs: Medications for heart conditions, hypertension, and hyperlipidemia.

Central Nervous System (CNS) Drugs: Products for neurological and psychiatric disorders.

Gastrointestinal Drugs: Medications for digestive system issues.

Respiratory Drugs: Treatments for asthma, COPD, and other respiratory conditions.

Endocrine System Drugs: Including treatments for diabetes and hormonal imbalances.

Active Pharmaceutical Ingredients (APIs): They also produce and supply raw materials for other pharmaceutical manufacturers.

Biologics and Biosimilars: Advanced therapeutic products.